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Abstract: Vascular inflammation plays a key role in the pathogenesis and progression of 
atherosclerosis, a main complication of diabetes. The present study investigated whether an 
aqueous  extract  of  Portulaca  oleracea  (AP)  prevents  the  TNF-α-induced  vascular 
inflammatory  process  in  the  human  umbilical  vein  endothelial  cell  (HUVEC).  The 
stimulation of TNF-α induced overexpression of adhesion molecules affects vascular cell 
adhesion molecule (VCAM)-1, intercellular adhesion molecule (ICAM)-1 and E-selectin 
for  example.  However,  AP  significantly  suppressed  TNF-α-induced  over-expression  of 
these adhesion molecules in a dose-dependent manner. In addition, pretreatment with AP 
dose-dependently reduced an increase of the adhesion of HL-60 cells to TNF-α-induced 
HUVEC.  Furthermore,  we  observed  that  stimulation  of  TNF-α  significantly  increased 
intracellular reactive oxygen species (ROS) production. However, pretreatment with AP 
markedly  blocked  TNF-α-induced  ROS  production  in  a  dose-dependent  manner.  The 
western blot and immunofluorescence analysis showed that AP inhibited the translocation 
of p65 NF-κB to the nucleus. In addition, AP suppressed the TNF-α-induced degradation 
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of IκB-α and attenuated the TNF-α-induced NF-κB binding. AP also effectively reduced  
TNF-α-induced  mRNA  expressions  of  monocyte  chemoattractant  protein  (MCP)-1  and 
interleukin (IL)-8 in a dose-dependent manner. Taken together, AP prevents the vascular 
inflammatory process through the inhibition of intracellular ROS production and NF-κB 
activation as  well as  the reduction of  adhesion molecule  expression in  TNF-α-induced 
HUVEC. These results  suggested that AP  might  have a potential therapeutic effect  by 
inhibiting the vascular inflammation process in vascular diseases such as atherosclerosis.  
Keywords:  Portulaca oleracea; inflammation; NF-κB; reactive oxygen species  (ROS); 
atherosclerosis 
 
1. Introduction 
Recent investigations of atherosclerosis have focused on vascular inflammation, providing novel 
insight  into  mechanisms  of  disease.  Much  evidence  has  demonstrated  that  inflammatory  events 
contribute  at  each  stage  in  the  development  of  clinically  significant  atherosclerosis  [1,2].  The 
recruitment of circulating monocytes/leukocytes to inflamed sites in the arterial wall is one of the 
earliest  detectable  events  in  atherogenesis.  Endothelial  cells  recruit  leukocytes  by  selectively 
expressing major adhesion molecules on the surface, for example, vascular cell adhesion molecules 
(VCAM-1), intercellular adhesion molecules (ICAM-1), and endothelial cell selectin (E-selectin) [3]. 
The pro-inflammatory cytokine, tumor necrosis factor (TNF)-α, is a prototype “activation agonist” that 
modulates  leukocyte  adhesion  and  transmigration  in  vascular  inflammatory  diseases  including 
atherosclerosis [4]. Previous studies have indicated that cytokines such as TNF-α change the shape and 
motility of endothelial cells, which could contribute to vascular leakage at the site of inflammation and 
that  such  cytokines  stimulate  an  increase  in  the  expression  of  cell  adhesion  molecules  [5,6].  
An increased expression of adhesion molecules by endothelial cells in human atherosclerotic lesions 
may lead to further recruitment of leukocytes to atherosclerotic sites.  
TNF-α  also  activates  signaling  cascades  that  regulate  the  activation  and  translocation  of  
redox-sensitive transcription factor NF-κB, an obligatory mediator of the inflammatory response that 
causes  transcriptional  activation  of  genes  encoding  adhesion  molecules  [7]. Previous  studies  have 
shown that NF-κB activation is required for the up-regulation of adhesion molecules such as ICAM-1 
and VCAM-1, which are responsible for monocyte adhesion and increased vascular inflammation [8,9]. 
Increased oxidative stress  in  vascular cells  is  implicated in  the pathogenesis of atherosclerosis. 
Reactive oxygen species (ROS) are important mediators in cellular injury, specifically, as a factor in 
endothelial cell damage. A potent factor in causing intracellular ROS formation in endothelial cells is 
TNF-α,  a  pleiotropic  inflammatory  cytokine  [10].  In  addition,  ROS  may  serve  as  a  common 
intracellular  messenger  for  various  redox-sensitive  transcription  pathways  that  induce  adhesion 
molecule expression in vascular endothelial cells [2,11]. Recent studies showed that substances with 
antioxidant  activity  could  scavenge  intracellular  ROS  and  inhibit  endothelial  adhesiveness  to 
monocytes by reducing the expression of various adhesion molecules [12,13].  Int. J. Mol. Sci. 2012, 13  5630 
 
 
Portulaca oleracea L. (Portulacaceae) is an edible plant and has been used as a folk medicine in 
many countries, acting as a diuretic, febrifuge, antiseptic, antispasmodic and vermifuge [14,15]. It has 
been  shown  to  display  pharmacological  roles,  including  antibacterial  [16],  analgesic  [17], skeletal  
muscle-relaxant [18] and wound-healing [19] activities. Many studies have also shown that the major 
bioactive components of Portulaca oleracea are flavonoids, coumarins, monoterpene glycoside and 
alkaloids [20,21]. Some research results indicated that Portulaca oleracea could also be used to reduce 
the incidence of cardiovascular diseases [22]. However, there are no reports on the efficacy of an 
aqueous extract of Portulaca oleracea (AP) on either the expression of the cell adhesion molecules or 
the  adhesion  monocytes  to  endothelial  cells  through  the  NF-κB  signaling  pathway.  Therefore  we 
investigated  the  anti-vascular  inflammatory  effect  and  molecular  mechanism  of  AP  in  the  
TNF-α-induced vascular inflammation process in primary cultured human umbilical vein endothelial 
cells (HUVEC).  
2. Results and Discussion 
The major finding of this study indicated that pretreatment with AP significantly suppressed the 
TNF-α-induced intracellular ROS production and up-regulation of adhesion molecules in HUVECs by 
inhibiting  the  NF-κB  signaling  pathway.  The  cytotoxicity  was  examined  using  an  MTT  assay, 
performed at 1–200 μg/mL concentration of AP. When incubated with AP (1–200 μg/mL) for 24 h, cell 
viability did not show significant difference at each concentration; cytotoxicity observed at 200 μg/mL 
AP (Figure 1a). Therefore 100 μg/mL AP concentration was used as the maximum dose. Increased 
expression of cell adhesion molecules is an important aspect of inflammatory changes associated with 
atherosclerosis  and  contributes  to  the  activation  and  recruitment  of  lymphocyte  from  adventitial 
vessels and the arterial lumen to the vessel wall [2]. Various agonists including cytokines such as  
TNF-α  and  chemokines  induce  endothelial  cell  activation.  TNF-α  stimulation  of  endothelial  cells 
activates  the  cell  surface  expression  of  adhesion  molecules  such  as  ICAM-1,  VCAM-1  and  
E-selectin  [6,23].  The  effects  of  AP  on  the  VCAM-1,  ICAM-1  and  E-selectin  expressions  in  
TNF-α-induced HUVEC were determined by ELISA. This data indicated that ICAM-1, VCAM-1, and 
E-selectin were expressed at low levels on unstimulated endothelial cells. However, treatment with cells 
to TNF-α (10 ng/mL) for 6 h led to a marked increase of the surface expression of these cell adhesion 
molecules. Pretreatment with AP significantly inhibited the TNF-α-induced cell surface expressions of 
VCAM-1 and ICAM-1 in a dose-dependent manner. However, E-selectin expression did not show 
significant difference (Figure 1b). The inhibitory effect of AP on the expression of the cell adhesion 
molecules was further confirmed by western blot analysis. As shown in Figure 2, the unstimulated 
HUVEC expressed low levels of ICAM-1 and VCAM-1 and E-selectin. Upon stimulation with TNF-α, 
a substantial increase in the expression of all these three molecules was observed. Pretreatment with 
AP significantly inhibited the TNF-α-induced expression of ICAM-1, VCAM-1 and E-selectin in a 
dose-dependent  manner  (Figure  2a,b).  Thus,  AP  inhibited  the  TNF-α-induced  expression  of  cell 
adhesion molecules as measured using ELISA and confirmed by western blot analysis. Furthermore, 
the  adhesion  of  leukocytes  or  monocytes  to  the  vascular  endothelium  is  an  important  step  in  the 
reaction  to  inflammation  and  development  of  atherosclerotic  lesions.  During  early  stages  of 
atherosclerosis,  circulating  monocytes  adhere  to  endothelial  cells  that  line  the  vessel  wall  and Int. J. Mol. Sci. 2012, 13  5631 
 
 
transmigrate  through  the  endothelium  into  the  intimal  extracellular  matrix  [24].  The  recent  study 
demonstrated that a small number of monocytes adhered to unstimulated HUVECs [25], whereas there 
was a marked increase in monocyte adherence to HUVECs that had been exposed to TNF-α [26].  
To explore the effect of AP on endothelial cell-leukocyte interaction, we examined the adhesion of 
HL-60  cells  to  TNF-α-activated  HUVEC  under  static  conditions.  HUVEC  were  pretreated  with 
different concentrations of AP (10–100 μg/mL) and the intensity of cell adhesion was evaluated by the 
quantification of BCECF-AM staining method. Corresponding with results from ELISA, the adhesion 
of  HL-60  cells  to  TNF-α-stimulated  HUVECs  was  increased  about  4.5-fold  compared  with  the 
untreated cells, and this adhesion was markedly decreased by treatment with AP in a dose-dependent 
manner  (Figure  3).  Therefore,  we  found  that  treatment  with  AP  significantly  reduced  monocyte 
adhesion to TNF-α-induced HUVEC, which is due to the inhibition of adhesion molecules expression. 
These results suggested that AP could suppress the early pathogenesis of atherosclerosis by regulating 
the vascular inflammatory process. 
Figure 1. Effects of an aqueous extract of Portulaca oleracea (AP) on cytotoxicity and 
endothelial  cell  surface  expressions  of  vascular  cell  adhesion  molecules  (VCAM-1), 
intercellular  adhesion  molecules  (ICAM-1),  and  endothelial  cell  selectin  (E-selectin).  
(a) Confluent endothelial cell monolayers were incubated with various concentrations of 
AP for 24 h. Cell viability was determined by MTT assay; (b) The endothelial cells were 
pretreated with AP and then stimulated with pro-inflammatory cytokine, tumor necrosis 
factor (TNF)-α (10 ng/mL) for 6 h. Cell surface expressions of ICAM-1, VCAM-1, and  
E-selectin  were  analyzed  by  cell  ELISA,  as  described  in  the  Materials  and  Methods. 
Values are expressed as mean  S.E. of three individual experiments. *
 p < 0.05, **
 p < 0.01 
vs. control, 
 p < 0.01 vs. TNF-α alone.  
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Figure 2. Effect of AP on TNF-α-induced increases in protein expression of VCAM-1, 
ICAM-1,  and  E-selectin.  (a)  Primary  cultured  human  umbilical  vein  endothelial  cells 
(HUVECs)  were  pretreated  with  AP  and  then  stimulated  with  TNF-α  for  6  h.  After 
treatment, protein was extracted from the cells. VCAM-1, ICAM-1 and E-selectin protein 
levels were determined by western blot analysis; (b) Quantitative data are expressed as 
VCAM-1 (black), ICAM-1 (gray), and E-selectin (dark gray) normalized to β-actin, and 
the  results  are  expressed  as  the  fold  of  the  control.  Each  electrophoretogram  is 
representative of the results from five independent experiments. *
 p < 0.05, ** p < 0.01 vs. 
control, 
 p < 0.05,
  p < 0.01 vs. TNF-α alone. 
 
   
CA
Ms e
xpre
ss
ion
(Fold of untre
ate
d contr
ol)
0.0
0.5
1.0
1.5
2.0
2.5
3.0
VCAM-1
ICAM-1
E-selectin
- + + TNF- (10 ng/ml)
AP (g/ml)
+ + +
- - 10 25 50 100
****
**
## ## ##
##
##
#
#
#
#
B.Int. J. Mol. Sci. 2012, 13  5633 
 
 
Figure 3. Effect of AP on TNF-α-induced adhesion of HL-60 cells to HUVEC. Adhesion 
of fluorescence-labeled HL-60 cells to HUVEC was determined as described in Materials 
and  Methods.  (a)  Control;  (b)  TNF-α  (10  ng/mL);  (c)  co-treated  with  TNF-α  and  AP  
(10 µg/mL); (d) co-treated with TNF-α and AP (25 µg/mL); (e) co-treated with TNF-α and 
AP (50 µg/mL); (f) co-treated with TNF-α and AP (100 µg/mL). The amounts of adherent  
HL-60 cells were monitored by fluorescence microscopy. Low panel represents ratio of 
fluorescence  intensity.  Values  are  expressed  as  mean    S.E.  of  five  independent 
experiments with triplicate dishes. **  p  < 0.01 vs.  control, 
 p  < 0.05, 
 p  < 0.01 vs.  
TNF-α alone.  
 
Induction  of  chemotactic  cytokines  such  as  IL-8  and  MCP-1  is  thought  to  play  a  key  role  in 
monocyte recruitment and adhesion to endothelial cells in atherosclerosis [27]. Previous studies have 
shown that chemokines and adhesion molecules are involved in causing atherosclerosis by promoting 
directed migration of inflammatory cells. Interleukin-8 (IL-8) is a C–X–C chemokine and acts as a 
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chemoattractant  of  neutrophils,  whereas  monocyte  chemoattractant  protein-1  (MCP-1)  is  a  C–C 
chemokine and functions mainly as a chemoattractant of monocytes/macrophages [28]. Both factors 
are secreted from endothelial cells and have been implicated in the processes leading to atherosclerosis. 
To understand the mechanisms responsible for inhibition of MCP-1 and IL-8 expression by AP, we 
examined whether AP blocks the induction of their transcript levels. We performed a RT-PCR analysis 
on isolated RNA in HUVEC. This data indicated that the unstimulated endothelial cells had low levels 
of MCP-1 and IL-8 mRNA expression. Stimulation with TNF-α induced a marked increase in MCP-1 
and IL-8 mRNA levels, while pretreatment with AP led to a significant reduction in their transcript 
levels (Figure 4). These results indicated that AP inhibited the transcription of MCP-1 and IL-8 genes 
under  cytokine  stimulation.  Therefore,  AP  may  be  effective  in  suppression  of  the  vascular 
inflammatory process associated with the development of atherosclerosis. 
Figure 4. Effect of AP on TNF-α-induced increase of monocyte chemoattractant protein-1 
(MCP-1) (a) and Interleukin-8 (IL-8) (b) mRNA expression. HUVEC were pretreated with 
AP and then stimulated with TNF-α. MCP-1 and IL-8 mRNA expression was determined 
by RT-PCR. Values are expressed as a fold of basal value and are the mean ±  S.E. of five 
independent experiments.
 ** p < 0.01 vs. control, 
 p < 0.01 vs. TNF-α alone. 
 
It has been also shown that activation of the transcription factor NF-κB by TNF-α is required for the 
transcriptional activation of endothelial cell adhesion molecules [29]. Nuclear factor κB (NF-κB) has 
been  implicated  in  the  transcriptional  activation  of  numerous  genes,  including  those  relevant  to 
atherogenesis  and  inflammatory  responses  [30,31].  NF-κB  is  found  in  an  inactive  form  in  the 
cytoplasm  and  appears  associated  with  its  inhibitor  molecule  (I-κB).  On  stimulation,  rapid 
phosphorylation and degradation of IκBα allows NF-κB to translocate into the nucleus and regulate 
transcription of the target genes. In cultured human and bovine vascular endothelial cells, p50/p65 
heterodimers of NF-κB appear to play a major role in cytokine-dependent transcription of E-selectin, 
ICAM-1,  and  VCAM-1  genes  [32].  Furthermore,  activation  of  NF-κB  occurs  in  the  vascular 
endothelium covering atherosclerotic lesions in humans [33]. To study the effect of AP on NF-κB 
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activation in TNF-α-induced HUVEC, electrophoretic mobility shift assay (EMSA) was performed. As 
shown in Figure 5a, stimulation with TNF-α increased the level of NF-κB-DNA-binding activity. This 
finding was caused by significant retardation in the mobility of the labeled oligonucleotide. In contrast, 
AP markedly inhibited the NF-κB-DNA-binding activity in the nuclear extract from TNF-α-induced 
HUVECs.  These  results  therefore,  showed  that  AP  inhibits  the  TNF-α-induced  NF-κB  activation. 
Using western blot analysis, NF-κB p65 protein was expressed abundantly in cytoplasm but less in the 
nucleus of unstimulated cells. However, translocation of NF-κB p65 from the cytoplasm to the nucleus 
was significantly increased in TNF-α-stimulated cells. TNF-α-dependent translocation of NF-κB p65 
to the nucleus was markedly suppressed by pretreatment with AP. In contrast, NF-κB p65 protein in 
the  cytosolic  extract  significantly  increased  following  treatment  with  AP.  Thus,  AP  inhibited  the  
TNF-α-induced  increase  of  NF-κB  p65  expression  levels.  Pretreatment  with  AP  inhibited  IκBα 
degradation in  a dose dependent  manner. Upon induction  with  TNF-α, the intensity of  IκBα  was 
significantly reduced. In contrast, pretreatment of cells with AP significantly inhibited the degradation 
of  IκBα  in  TNF-α-induced  HUVECs  (Figure  5b).  This  was  further  confirmed  by  fluorescence 
microscopy showing that while cells are in a quiescent state, NF-κB p65 protein was mainly located in 
cytoplasm and only a few cells showed a strongly positive nuclear stain, whereas TNF-α profoundly 
increased  the  number  of  nuclei  for  the  p65  NF-κB.  However,  AP-treated  cells  represented  the 
diminished staining level of nuclear p65 in a dose dependent manner (Figure 6). 
Figure  5.  Effect  of  AP  on  TNF-α-induced  NF-κB  activation  in  HUVECs.  Cells  were 
preincubated with AP and treated with 10 ng/mL of TNF-α. (a) Nuclear protein extracts 
were prepared, and electrophoretic mobility shift assay (EMSA) was performed using the 
biotin-labeled  double-stranded  oligonucleotide  containing  consensus  NF-κB  binding 
sequences, as described in Materials and Methods; (b) Effect of AP on TNF-α-induced  
NF-κB  p65  translocation  into  nucleus  and  IκBα  degradation  in  HUVEC.  Each 
electrophoretogram is representative of the results from three independent experiments. 
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Figure  6.  Effect  of  AP  on  TNF-α-induced  NF-κB  nuclear  translocation.  Subcellular 
localization  of  the  p65  NF-κB  subunit  was  assayed  with  the  cell  immunofluorescence 
technique. HUVEC were stained with an antibody versus NF-κB (FITC; green staining), 
and  nuclei  were  counterstained  with  DAPI  (blue  staining).  Each  electrophoretogram  is 
representative of the results from three individual experiments. 
 
Emerging evidence suggests that TNF-α signaling cascade may cause oxidative stress due to the 
production of reactive oxygen species, which in turn temporally regulate NF-κB activity by IκB kinase 
with  subsequent  degradation  of  IκBα  [34,35].  Also,  a  number  of  antioxidants  and  free  radical 
quenchers have also been shown to block the NF-κB activation. Reactive oxygen species (ROS) may 
up-regulate pro-inflammatory gene expression by activating NF-κB, a process that is itself sensitive to 
the cellular redox state [36]. Therefore, there has been increasing interest in developing the potential 
therapeutic value of ROS-antioxidants as inhibitors of NF-κB from various plants [37]. To examine the 
protective effect of AP on TNF-α-induced intracellular ROS production in HUVECs, we measured  
DCF-sensitive cellular ROS. This data showed that the intracellular ROS production was significantly 
increased  by  stimulation  of  TNF-α.  Pretreatment  with  AP  dose-dependently  suppressed  the  
TNF-α-induced ROS  production in  HUVECs  (Figure 7). These result suggested that antioxidative 
activity of AP could contribute in part to its inhibitory effects. Several studies have reported that the 
oxidative stress might contribute to NF-κB-dependent inflammatory responses. Recent studies reported 
that  antioxidant  NAC  suppresses  vascular  NF-κB  activation,  and  this  inhibition  reduces  the 
pathological  thickening  of  the  arterial  wall  [38].  NF-κB  has  been  shown  to  be  ROS-sensitive. 
Therefore, we suggest that the antioxidant property of AP was  able to inhibit the TNF-α-induced 
activation of NF-κB.  
Recently, our published data suggested that P. oleracea ameliorates both vascular inflammation and 
diabetic nephropathy in db/db mice [39]. The major bioactive components of Portulaca oleracea are 
flavonoids, coumarins, monoterpene glycoside and alkaloids. Furthermore, P. oleracea is a rich source 
of  omega-3  fatty  acids,  gallotannins,  kaempferol,  quercetin,  apigenin,  and  glutathione  [40,41]. 
However, the mechanism of action and its compounds have not been clarified [42]. Recently, it has 
NF-κB
DAPI
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been reported that betacyanins from Portulaca oleracea, anthocyanins, ameliorate cognition deficits 
and attenuate oxidative damage in the brains of senescent mice [43]. Generally, polysaccharides and 
flavones  are  the  usual  anti-diabetic  compounds  in  herbs  [44,45].  We  speculate  that  various 
polysaccharides or flavones could participate in the inhibitory effect of vascular inflammation. Thus, 
further work on isolation and purification of each compound from AP will be done to identify the 
hypoglycemic effective compounds. 
Figure 7. Effect of AP on TNF-α-induced ROS production. HUVECs were pretreated with 
AP (10–100 µg/mL) or NAC (50 µM) for 30 min and then stimulated with/without TNF-α 
(10 ng/mL) for 1 h. The fluorescence intensity of cells was measured using a fluorescence 
microplate. Values are expressed as a mean percentage of the fluorescence intensity ±  S.E. 
of  five  individual  experiments.  **  p  <  0.01  vs.  control, 
  p  <  0.05, 
  p  <  0.01  vs.  
TNF-α alone. 
 
3. Experimental Section  
3.1. Extraction of Portulaca oleracea  
The  Portulaca  oleracea  was  purchased  from  the  Herbal  Medicine  Co-operative  Association  in 
Jeonbuk Province, Korea. Herbarium voucher specimen (No. HBE121) was deposited in the herbarium 
of the Professional Graduate School of Oriental Medicine, Wonkwang University, Iksan, Jeonbuk, 
South Korea. Dried aerial parts of P. oleracea (400 g) were extracted with 5.5 L of boiled distilled 
water at 100 ° C for 2 h. The aqueous extract was centrifuged at 1000 g for 20 min at 4 ° C and the 
supernatant  was  filtered  with  a  Whatman  No.3  filter  paper,  and  then  concentrated  using  a  rotary 
evaporator. The supernatant extract was lyophilized to produce a powder, which was then kept at 4 ° C 
until use in the experiments. The yield of the water extract of P. oleracea was approximately 22.8% of 
plant powder. 
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3.2. Cell Culture 
Primary  cultured HUVEC and endothelial cell growth medium  (EGM-2) containing 2.5%  fetal 
bovine serum (FBS) and growth supplements were purchased from Cambrex (East Rutherford, NJ). 
HUVEC  which  were  used  between  passages  three  and  eight  were  maintained  in  EGM-2  in  a 
humidified chamber containing 5% CO2 at 37 ° C.  
3.3. Determination of Cell Based ELISA  
ELISA was used to determine the level of ICAM-1, VCAM-1, and E-selectin expression on the cell 
surface, as previously described with minor modifications [46]. Briefly, HUVEC were fixed by 1% 
paraformaldehyde and exposed to mouse anti-human ICAM-1, VCAM-1, or E-selectin antibodies at 
1:1000 dilution in phosphate-buffered saline (PBS) containing 1% bovine serum albumin (BSA) for  
2  h  at  room  temperature.  The  cells  were  washed  and  incubated  with  a  horseradish  peroxidase  
(HRP)-conjugated  secondary  antibody.  The  expression  of  VCAM-1,  ICAM-1,  or  E-selectin  was 
quantified by adding a peroxidase substrate solution (40 mg o-phenylenediamine and 10 µL 30% H2O2 
in 100 mL 0.05 M citrate-phosphate buffer). After incubation for 30 min at 37 ° C, the reaction was 
stopped by addition of 5 N H2SO4, and the absorbance of each well was measured at 490 nm by a 
Multiskan microplate reader (Thermo LabSystems Inc., Franklin, MA). 
3.4. Monocyte-Endothelial Cell Adhesion Assay 
The cell adhesion assay was modified as described [47]. Briefly, regularly passaged HL-60 cells 
were  labeled  with  10  μg/mL  2',7'-bis-(carboxyethyl)-5,6-carboxyfluorescein  acetoxymethyl  ester 
(BCECF/AM,  Sigma  Chemical  Co.,  St.  Louis,  MO)  at  10  μM  final  concentration  in  RPMI-1640 
medium containing 10% FBS at 37 °C  for 30 min. The labeled cells were harvested by centrifugation 
and washed three times with PBS before suspension in the medium, and added to HUVEC in six-well 
culture plates at 4 ×  10
5 cells/mL. The co-incubation was done at 37 °C  for 1 h and nonadhering  
HL-60 cells (American Type Culture Collection, Manassas, VA) were removed by stringent washing 
two times with PBS. HL-60 cells bound to HUVEC were measured by fluorescence microscopy (Leica 
DMIRB, Leica, Germany) and were lysed with 50 mM Tris-HCl, pH 8.0, containing 0.1% sodium 
dodecyl sulfate (SDS). The fluorescent intensity was measured using a spectrofluorometer (F-2500, 
Hitachi, Tokyo, Japan) at an excitation and emission wavelength of 485 nm and 535 nm, respectively. 
The adhesion data are represented in terms of the percentage change compared with the control values.  
3.5. Preparation of Cytoplasmic and Nuclear Extracts  
The  cells  were  rapidly  harvested  by  sedimentation  and  nuclear  and  cytoplasmic  extracts  were 
prepared on ice as previously described by the method of Mackman et al. [19]. Cells were harvested 
and washed with 1 mL buffer A (10 mM HEPES, pH 7.9, 1.5 mM MgCl2, 19 mM KCl) for 5 min at 
600 g. The cells were then resuspended in buffer A and 0.1% NP 40, left for 10 min on ice to lyse the 
cells and then centrifuged at 600 g for 3 min. The supernatant was saved as cytosolic extract. The 
nuclear  pellet  was  then  washed  in  1  mL  buffer  A  at  4200  g  for  3  min,  resuspended  in  30  µL  
buffer C (20 mM HEPES, pH 7.9, 25% glycerol, 0.42 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA), Int. J. Mol. Sci. 2012, 13  5639 
 
 
rotated for 30 min at 4 °C , then centrifuged at 14,300 g for 20 min. The supernatant was used as 
nucleus extract.  
3.6. Protein Extraction and Western Blot Analysis 
Cell  homogenates  (40  μg  of  protein)  were  separated  on  10%  SDS-polyacrylamide  gel 
electrophoresis and transferred to nitrocellulose paper. Blots were then washed with H2O, blocked with 
5%  skimmed  milk  powder  in  Tris-Buffered  Saline  Tween-20  (TBST)  (10  mM  Tris-HCl,  pH  7.6,  
150 mM NaCl, 0.05% Tween-20) for 1 h, and incubated with the appropriate primary antibody at 
dilutions recommended by the supplier. Then the membrane was washed and primary antibodies were 
detected with goat anti-rabbit-IgG or rabbit anti-mouse-IgG conjugated to horseradish peroxidase, and 
the bands were visualized with enhanced chemiluminescence (Amersham Bioscience, Buckinghamshire, 
UK). Protein expression levels were determined by analyzing the signals captured on the nitrocellulose 
membranes using the ChemiDoc image analyzer (Bio-Rad Laboratories, Hercules, CA). 
3.7. Electrophoretic Mobility Shift Assay 
Electrophoretic  mobility  shift  assay  (EMSA)  for  NF-κB  was  performed  using  TM  a 
lightshiftchemiluminescent EMSA kit (Pierce, Rockford, IL, USA) by following the manufacturer’s 
protocol. To start with, DNA was biotin labeled using the Biotin 3' endlabeling kit (Pierce, Rockford, 
IL, USA).  Briefly, in  a 50  µL reaction buffer, 5 pmol of double-stranded NF-κB oligonucleotide  
5'-GAT CTC AGA GGG GAC TTT CGA GAG A-3'; 3'-CTA GAG TCT CCC CTG AAA GGC TCT 
CT-5' was incubated in a microcentrifuge tube with 10 µL of 5· terminal deoxynucleotidyl transferase 
(TdT) buffer, 5 µL of 5 M biotin-N4-CTP, 10 U of diluted TdT, and 25 µL of ultrapure water and 
incubated at 37 ° C for 30 min. The reaction was stopped with 2.5 µL of 0.2 M EDTA. To extract 
labeled DNA, 50 µL of chloroform: isoamyl alcohol (24:1) was added to each tube and centrifuged 
briefly at 13,000 rpm. The top aqueous phase containing the labeled DNA was removed and saved for 
binding reactions. Each binding reaction contained 1 binding buffer (100 mM Tris, 500 mM KCl,  
10 mM dithiothreitol, pH 7.5), 2.5% glycerol, 5 mM MgCl2, 50 ng/µL poly (dI-dC), 0.05% NP-40,  
5 µg of nuclear extract and 20–50 fm of biotin-endlabeled target DNA. The content was incubated at 
room temperature for 20 min. To this reaction mixture, 5 µL of 5×  loading buffer was added, subjected 
to gel electrophoresis on a native polyacrylamide gel, and transferred to a nylon membrane. When the 
transfer was complete, DNA was crosslinked to the membrane at 120 mJ/cm
2 using a UV crosslinker 
equipped  with  254  nm  bulbs.  The  biotin-endlabeled  DNA  was  detected  using  streptavidin-HRP 
conjugate and a chemiluminescent substrate. The membrane was exposed to using digitalized scientific 
software program Quantity One
® (Silk Scientific Corporation, Orem, UT, USA). 
3.8. RNA Isolation and RT-PCR Analysis  
Total RNA was isolated from cultured endothelial cells using a commercially available kit (RNeasy 
Mini Kit; Qiagen, Valencia, CA, USA). Briefly, cells were washed with PBS, and then RLT buffer 
(containing  10%  β-mercaptoethanol)  was  used.  Supernatants  were  transferred  into  RNase-free 
microcentrifuge tubes, 70% ethanol was added, and the mixture was applied to a Total RNA Mini Int. J. Mol. Sci. 2012, 13  5640 
 
 
column,  centrifuged,  and  the  flow-through  discarded.  Bound  RNA  in  the  column  was  eluted  by  
RNase-free ddH2O, and RNA was stored at −80 ° C. The OD260 and OD260/280 values were measured 
with a spectrophotometer to determine the RNA concentrations. Briefly, in the first step, cDNA was 
prepared from 500 ng RNA by reverse transcription in a final volume of 20 µL in an Opticon MJ 
Research instrument. The samples were incubated at 37 ° C for 60 min and 94 ° C for 5 min. cDNA was 
stored at −20 ° C. cDNA samples were analyzed for the specific cDNA of VCAM-1, MCP-1, IL-8, and 
GAPDH by PCR amplification using specific primers (Table 1). Template cDNA and 50 nM primers 
were  placed  in  PCR Pre-mix  according  to  the  manufacturer’s  specification  (Bioneer,  Korea).  The 
amplification profile was as follows: an initial cycling at 94 ° C for 15 min followed by 45 cycles of  
94 ° C, 20 s; 60 ° C, 20 s; 72 ° C, 30 s and a final extension of 72 ° C for 5 min. The PCR products were 
subjected to 1.2% agarose gel electrophoresis. Quantitative data normalized to GAPDH were obtained 
from  a  densitometer  and  analyzed  with  the  included  Quantity  One  software  (Silk  Scientific 
Corporation, Orem, UT, USA). 
Table 1. Oligonucleotide primer used for RT-PCR.  
Primer  Sequence  
VCAM-1 
sense : CAAATCCTTGATACTGCTCATC 
anti-sense : TTGACTTCTTGCTCACAGC 
MCP-1 
sense : CAGCCAGATGCAATCAATGC 
anti-sense : GTGGTCCATGGAATCCTGAA 
IL-8 
sense : GCATAAAGACATACTCCAAACC 
anti-sense : ACTTCTCCACAACCCTCTG 
GAPDH 
sense : GCACCGTCAAGGCTGAGAAC 
anti-sense : TGGTGGTGAAGACGCCAGT 
3.9. Immunofluorescence Microscopy 
HUVECs were seeded on sterile slide coverslips in 6 well plates overnight and pretreated with AP 
before  being  stimulated  with  TNF-α.  After  several  washes  with  PBS,  cells  were  fixed  with  4% 
paraformaldehyde for 30 min at room temperature and permeabilized with 0.1% Triton-100 in PBS for 
30 min. The cells were overlaid with protease-free BSA for 10 min, rinsed with PBS and incubated 
with anti-NF-κB p65 (Santa Cruz Biotechnology, CA, USA) for 1 h at room temperature. Cells were 
washed three times with PBS and then incubated with FITC-conjugated goat anti-rabbit IgG as the 
secondary antibody (Sigma, St Louis, MO, USA). The slides were incubated at 37 ° C for 45 min, and 
nuclear staining was performed with DAPI (Molecular Probe, Eugene, OR, USA). Cells were finally 
washed three times with PBS, coverslips were mounted with Dako Fluorescent mounting medium onto 
glass slides, and examined under a fluorescence microscope (Axiovision 4, Zeiss, Germany). 
3.10. Intracellular ROS Production Assay 
The  fluorescent  probe,  5-(and-6)-chloromethyl-2',7'-dichlorodihydro-fluorescein  diacetate  
(CM-H2DCF-DA), was used to determine the intracellular generation of ROS by stimulation of TNF-α. 
Briefly,  the  confluent  HUVECs  in  the  24-well  plates  were  pretreated  with  AP  for  30  min.  After Int. J. Mol. Sci. 2012, 13  5641 
 
 
removing the AP from the wells, the cells were incubated with 20 μM DCF-DA for 30 min. The cells 
were then stimulated with TNF-α (10 ng/mL), and the fluorescence intensity (relative fluorescence 
units) was measured at an excitation and emission wavelength of 485 nm and 530 nm, respectively, 
using a fluorescence spectrophotometer (F-2500, Hitachi, Tokyo, Japan). 
3.11. Statistical Analysis 
Values  were  expressed  as  mean  ±   S.E.  Statistical  analyses  were  performed  using  analysis  of 
variance followed by the Student’s t-test and one-way ANOVA. Differences with a value of p < 0.05 
were considered statistically significant. 
4. Conclusions  
Vascular inflammation induced by cytokine occurs early in the development of atherosclerosis, and 
leads  to  endothelial  dysfunction. The present  study  indicated that AP  significantly suppressed the 
following events in cultured vascular endothelial cells; TNF-α-induced intracellular ROS formation 
and the redox-sensitive NF-κB activation via the suppression IκB degradation and phosphorylation, 
cell adhesion molecules expression, and the adhesion to monocytes. These results demonstrate that AP 
has  anti-vascular inflammatory activity  and AP  may be useful  in  the prevention and treatment  of 
vascular  inflammatory  diseases.  Thus,  this  data  has  cast  a  new  light  on  the  actions  of  
Portulaca oleracea and its potential benefits in preventing atherosclerosis.  
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